AJMC August 29, 2025
Yale Podnos, MD, MPH, FACS, discusses strategies to address social determinants of health in oncology, improve clinical trial enrollment for underserved communities, and leverage value-based care models to reduce financial toxicity and ensure equitable cancer care.
At a recent Institute for Value-Based Medicine® event, Yale Podnos, MD, MPH, FACS, chief medical officer at The Oncology Institute, discussed the growing importance of addressing social determinants of health (SDOH) in oncology care and how value-based care models can help reduce disparities. He highlighted practical strategies for screening patients in day-to-day practice, emphasized the role of trust and language accessibility in improving clinical trial enrollment, and explored innovative ways to reduce financial toxicity and ensure equitable access to evidence-based cancer care. Podnos also...
Today's Sponsors
Today's Sponsor